SFRP1 Promoter Hypermethylation as a Predictor of Survival and Gemcitabine Efficiency in Patients with Stage IV Pancreatic Adenocarcinoma

Benjamin Stubbe, Stine Dam Henriksen, Poul Henning Madsen, Anders Christian Larsen, Henrik Bygum Krarup, Inge Søkilde Pedersen, Martin Nygård Johansen, Ole Thorlacius-Ussing

Research output: Contribution to conference without publisher/journal › Poster › Research

21 Downloads (Pure)

1 Journal article

1 results

2021
Validation of SFRP1 Promoter Hypermethylation in Plasma as a Prognostic Marker for Survival and Gemcitabine Effectiveness in Patients with Stage IV Pancreatic Adenocarcinoma
Stubbe, B. E., Henriksen, S. D., Madsen, P. H., Larsen, A. C., Krarup, H. B., Pedersen, I. S., Johansen, M. N. & Thorlacius-Ussing, O., 15 Nov 2021, In: Cancers. 13, 22, 15 p., 5717.
Research output: Contribution to journal › Journal article › Research › peer-review

Open Access
File
7 Citations (Scopus)

23 Downloads (Pure)